Cystic fibrosis screening using the College panel: platform comparison and lessons learned from the first 20,000 samples
Charles M Strom1, Donghui Huang, Arlene Buller
1Molecular Genetics Laboratory, Quest Diagnostics Nichols Institute, San Juan Capistrano, California.
Purpose:
To determine the accuracy of two commercially available kits for cystic fibrosis (CF) genotyping and determine allele frequencies for the ACMG/ACOG recommended mutations.
Methods:
A total of 1,040 consecutive analyses using Roche CF Gold Strips and the ABI CF Genotyper were performed. Subsequently we performed analyses of 20,103 samples.
Results:
Both kits accurately determined CF genotypes. The I148T mutation was found >100 times more frequently in carrier screening than in CF patients. Asymptomatic patients were identified who are compound heterozygotes for delta F508 and I148T. Four of 13 patients heterozygous for delta F508 and the IVS8-5T polymorphism had some symptoms of CF.
Conclusion:
Accurate and timely analysis can be performed for the ACMG CF panel. I148T is a low penetrance CF allele.
More Related Videos
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
